Biotechnology uses plant-based and waste resources to produce or process materials, chemicals and energy, offering green and sustainable alternatives to fossil fuels in everything from energy, to medicines and food packaging. IBioIC is a networking and support organisation that connects industry, academia and government to bring biotechnology processes and products to the global market. We do this by offering scale-up facilities, talent development, funding provision, and promotion of Scotland’s unique assets. IBioIC’s Governing Board sets the strategic direction of the Centre, ensuring all its activities contribute to its overall vision. The Governing Board is also responsible for compliance, financial oversight and risk management.
Glasgow, United Kingdom
Founded in 2014
11-50 Employees
Working industry
Biotechnology
Type of company
Service provider
Ownership structure
Nonprofit
Locations
1 Headquarter
Number of products
13 Products
Number of services
3 Services
Specialised areas
Integrated Bioprocessing, Sustainable feedstocks, Cell Factory Contruction and Process Physiology, Enzymes and Biocatalysis/ Biotransformation, Downstream processing, Biotechnology, Education
IBioIC offers a wide range of products and services
Product
BioTechnology Collaborative With Host Impact Solutions — IBioIC
Go to product >
Product
MEASUREMENT FOR INDUSTRIAL BIOTECHNOLOGY – AN EVENT BY NATIONAL PHYSICAL LABORATORY — IBioIC
Go to product >
Product
Industrial Biotechnology and Net Zero: The Role of Standards and Innovation with the British Standards Institution — IBioIC
Go to product >
Service
Absolute Antibody Expands Prometheus™ Antibody Humanization Service to Include Non-Murine Origin Species — IBioIC
Go to product >
Product
Comparison of Technologies for Real Time Analysis of 15 L Fermentation — IBioIC
Go to product >
Product
IBioIC - Innovation Support
Go to product >
Product
Addressing the global need for protein using next generation by-products — IBioIC
Go to product >
Service
Bioprocess Development for Sustainable Protein — IBioIC
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United Kingdom
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Get insights into the use cases of IBioIC
Use case
Investigating the use of daffodil extracts to treat heart failure — IBioIC
in this project co-funded with the High Value Biorenewables Network, the team successfully developed a process to extract alkaloids from daffodil biomass which could be used in the treatment of heart failure and are now in a position to apply for investment to take the process forward at scale in Sc
Use case
Food for fungi — IBioIC
IBioIC funded a collaboration between 3F BIO and the University of Strathclyde to develop and test a sustainable protein production process which advanced the company's progress towards commercialisation.
IBioIC operates in 1 country around the world
Get an overview of the locations of IBioIC
Location
Country
State
City
Headquarter
United Kingdom
Scotland
Glasgow
Some frequent questions that have been asked about IBioIC
Where is IBioIC located?
The company headquarter of IBioIC is located in Glasgow, Scotland, United Kingdom. It's worth noting, that the company may have more locations
How many employees does IBioIC approximately have?
As of the latest available information IBioIC has around 11-50 employees worldwide.
When was IBioIC founded?
IBioIC was founded in 2014
In which industries does IBioIC mainly work?
The company IBioIC has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to IBioIC
Bioeconomy Cluster Builder
Glasgow, United Kingdom
1-10 Employees
-
We deliver targeted events and provide innovation support and funding guidance to help companies use biotechnology to develop their products and services. Improve your environmental performance, increase efficiency and create value from co-products and waste streams. It therefore offers solutions to the traditional ‘take-make-dispose’, linear approach to production. Biotechnology has the power to transform key industries like food and drink manufacturing, textiles, chemical manufacturing, energy and pharmaceuticals. By delivering sustainable, bio-based alternatives to goods and services, the bioeconomy is core to achieving our Net Zero ambitions. The BCB provides signposting and expert guidance on accessing the best funding to meet your needs. Innovate UK KTN are experts in helping businesses navigate the complex innovation funding landscape. The BCB is a collaboration between the Industrial Biotechnology Innovation Centre (IBioIC) and Innovate UK KTN.
BioIndustry Association
London, United Kingdom
11-50 Employees
1989
Established in 1989, BIA is the award-winning trade association with over 600 members including:. BIA is the key thought leader for the sector – working across a wide range of related issues including policy, finance, science, regulatory, legal and talent on topics including engineering biology and techbio. We promote an ecosystem that enables innovative life science companies to start and grow successfully and sustainably, and we do this through Influence, Connect, Save. Deep Biotech encompasses innovative companies harnessing the power of engineering biology to tackle humanity's most pressing challenges, from environmental pollution to climate change. Leading precision medicine and nucleic acid therapy (NAT) innovators will harness their platforms to develop NAT drug candidates for novel gene targets with strong genetic association to sporadic ALS. It is a free three-day leadership and entrepreneurship training programme for up-and-coming life sciences entrepreneurs that we’ve developed and delivered with the Francis Crick Institute. In this article, Marsh’s Life Sciences industry practice leader Jenny Yu and experts from Kennedys take a look at the topic of AI in the life sciences sector, the associated risks regulation and potential liability issues, as well as how companies can seek to ‘future-proof’ themselves in the face of rapid change. This report aims to shine a light on some of the innovative companies using engineering biology to positively disrupt the environmentally damaging industries that modern society relies on.
Bio-based and biodegradable Industries Association
East Hertfordshire, United Kingdom
1-10 Employees
2015
The BBIA exists to champion the industrial bioeconomy to accelerate the development and adoption of bio-based and biodegradable materials and products through advocacy, collaboration, and education. Our vision is for a more sustainable future, where the UK is a global leader in developing, manufacturing, using and exporting bio-based and biodegradable solutions. BBIA is affiliated to many other organisations and groups who we collaborate with to further our joint missions:. BBIA’s Chair, Andy Sweetman, Marketing Manager at Futamura UK, talks about the role of the industrial bioeconomy. BBIA welcomes members from across the bio-based and biodegradable sector involved in designing and producing products to grow the bioeconomy. Articles of Association for the Bio-Based and Biodegradable Industries Association (BBIA) LTD. Welcome to the Bio-based and Biodegradable Industries Association (BBIA). The industrial bioeconomy, bio-based and bio-degradable materials offer a realistic opportunity to significantly reduce our reliance on fossil resources.
IBISBA
Toulouse, France
51-100 Employees
2017
IBISBA is a pan-European distributed research infrastructure dedicated to industrial biotechnology. Moreover, IBISBA is designed to meet 21st century science and technology challenges, providing the depth of pan-European cooperation required to harness the opportunities offered by powerful digital technologies, such as artificial intelligence. In this regard, IBISBA helps to reach EuropaBio’s projections, which anticipate that Europe’s industrial biotechnology will grow to up to 900,000-1,500,000 jobs in 2030. We provide a single access point to integrated services for end-to-end bioprocess development. IBISBA is a pan-European research infrastructure dedicated to Industrial Biotechnology. We provide a single access point to researchers from academia and industry across the globe to integrated services for end-to-end bioprocess development. In doing so, IBISBA accelerates the production and translation of cutting-edge knowledge into innovation for biomanufacturing. We develop smart biomanufacturing by integrating biotechnology with AI, digital twins and cloud technologies.
Irish Bioeconomy Foundation
Lisheen, Ireland
1-10 Employees
2017
Our mission is to promote the conversion of Ireland’s natural land & sea resources to high value products for the development of a sustainable bioeconomy that is globally competitive and creates local development. IBF will soon operate a modern Bioprocess pilot plant covering 1,700 sq. Support in confidential fundraising while leveraging IBF established International networks and relationships. Support in positioning and promoting your products, processes and brand within the Irish and EU Bioeconomy arena.
International Biotech Fashion Alliance
London, United Kingdom
1-10 Employees
2022
Our vision is a world where the evidence based benefits of biotech materials in fashion are fully realised and fully understood so that its positive impact can be maximised. As an industry we are committed to full legal compliance and the highest possible standards of product quality, safety, customer service, and excellent business practices in all areas. We are ideally placed to represent the interest of our members with offices in London, one of the world’s leading cultural, scientific and fashion centres, and in Brussels, at the heart of the EU. The International Biotech Fashion Alliance (IBFA) is the global representative body and incubator for the development and application of biotech materials in the fashion industry. We believe that the development and use of such technology heralds a progressive alternative to the use of animal or plastics-based materials in fashion, significantly shortening and improving supply chains and delivering significant benefits to the physical and natural environments, making the world a better place. To provide representation of the biotech materials fashion industry to key stakeholders and policy makers on a global basis. To agree and provide a framework for the development of independent and recognised standards safeguarding ecological, ethical and environmental responsibility. Provide services and business opportunities to our members including regular events, engagement opportunities and an online marketplace for their products.